| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872724 | The Annals of Thoracic Surgery | 2015 | 6 Pages |
Abstract
Survival after lobectomy for patients with stage I non-small cell lung cancer is impacted by lower Dlco, which can be used in the risk and benefit assessment when choosing therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mark F. MD, Chi-Fu Jeffrey MD, Matthew G. MD, Betty C. MD, David H. MD, Thomas A. MD, Mark W. MD,